Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells
Mike B. Barnkob
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Yale S. Michaels
(MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Violaine André
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Philip S. Macklin
(Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building)
Uzi Gileadi
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Salvatore Valvo
(Kennedy Institute of Rheumatology, University of Oxford)
Margarida Rei
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Corinna Kulicke
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Ji-Li Chen
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Vitul Jain
(Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford)
Victoria K. Woodcock
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Huw Colin-York
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Andreas V. Hadjinicolaou
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Youxin Kong
(Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford)
Viveka Mayya
(Kennedy Institute of Rheumatology, University of Oxford)
Julie M. Mazet
(Kennedy Institute of Rheumatology, University of Oxford)
Gracie-Jennah Mead
(Kennedy Institute of Rheumatology, University of Oxford)
Joshua A. Bull
(Wolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Radcliffe Observatory Quarter)
Pramila Rijal
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Christopher W. Pugh
(Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building)
Alain R. Townsend
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Audrey Gérard
(Kennedy Institute of Rheumatology, University of Oxford)
Lars R. Olsen
(Department of Health Technology, Technical University of Denmark, Ørsteds Plads)
Marco Fritzsche
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Tudor A. Fulga
(MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Michael L. Dustin
(Kennedy Institute of Rheumatology, University of Oxford)
E. Yvonne Jones
(Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford)
Vincenzo Cerundolo
(MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford)
Abstract Semaphorin-3A (SEMA3A) functions as a chemorepulsive signal during development and can affect T cells by altering their filamentous actin (F-actin) cytoskeleton. The exact extent of these effects on tumour-specific T cells are not completely understood. Here we demonstrate that Neuropilin-1 (NRP1) and Plexin-A1 and Plexin-A4 are upregulated on stimulated CD8+ T cells, allowing tumour-derived SEMA3A to inhibit T cell migration and assembly of the immunological synapse. Deletion of NRP1 in both CD4+ and CD8+ T cells enhance CD8+ T-cell infiltration into tumours and restricted tumour growth in animal models. Conversely, over-expression of SEMA3A inhibit CD8+ T-cell infiltration. We further show that SEMA3A affects CD8+ T cell F-actin, leading to inhibition of immune synapse formation and motility. Examining a clear cell renal cell carcinoma patient cohort, we find that SEMA3A expression is associated with reduced survival, and that T-cells appear trapped in SEMA3A rich regions. Our study establishes SEMA3A as an inhibitor of effector CD8+ T cell tumour infiltration, suggesting that blocking NRP1 could improve T cell function in tumours.
Mike B. Barnkob, Yale S. Michaels, Violaine André, et al. (2024). "Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells". Nature Communications. https://doi.org/10.1038/s41467-024-47424-z